Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Circulation|November 1, 1989
T cells in ventricular assist device patientsD F Termuhlen, D G Pennington, S T Roodman, et al.
The Annals of Thoracic Surgery|January 1, 1989
Use of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operationsD G Pennington, L R McBride, M T Swartz, et al.
Circulation|December 1, 1996
Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database GroupR J Rodeheffer, D C Naftel, L W Stevenson, et al.
ACS Omega|May 13, 2022
Identification of a Trm732 Motif Required for 2'-O-methylation of the tRNA Anticodon Loop by Trm7Holly M Funk, Daisy J DiVita, Hannah E Sizemore, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 12, 2006
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year reportJ A Kobashigawa, L W Miller, S D Russell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 8, 1998
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research DatabaseM R Costanzo, D C Naftel, M R Pritzker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trialJ A Kobashigawa, J M Tobis, R M Mentzer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 16, 2017
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsM Haas, A Loupy, C Lefaucheur, et al.
Kidney International|February 13, 1999
The Banff 97 working classification of renal allograft pathologyL C Racusen, K Solez, R B Colvin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groupsB Sis, M Mengel, M Haas, et al.
Pageof 25